Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
NCT04132960
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
186
Enrollment
OTHER
Sponsor class
Conditions
Breast Tumors
Interventions
DRUG:
DS-8201a
Sponsor
UNICANCER
Collaborators
[object Object]